質譜儀設備商在中國醫療檢測市場的商機與策略選擇─以X公司為例

Abstract

本研究以X公司為例，探討X公司的質譜儀設備在中國醫療檢測市場的策略選擇。從跨國企業在中國市場面臨的挑戰，看到中國醫療檢測市場的機會，根據外部政治經濟的變化，中國政府支持產業的本土製造，加上X公司內部其他產品線競爭激烈的困境急需找到下一個藍海市場，而醫療檢測市場又需要價格低與檢測項目多的產品，因此，針對X公司的質譜儀設備與檢測試劑盒的本地化生產的兩個維度，依照維持現狀、自行製造與外包生產，交叉組合做出八個策略。接者，依據產品與機會優缺點的分析，加上交易成本與產品上市時間的分析，得出X公司在中國的質譜儀設備與檢測試劑盒的本地化生產皆以外包生產的方式，最符合X公司在中國醫療檢測市場的最佳策略選擇。關鍵字:交易成本、策略選擇、醫療檢測市場、質譜儀

This study takes Company X as an example to discuss the strategic choices of Company X's mass spectrometer equipment in China's medical testing market. From the challenges faced by multinational companies in the Chinese market, to see the opportunities in the Chinese medical testing market, according to external political and economic changes, the Chinese government supports the local manufacturing of the industry, coupled with the dilemma of fierce competition in other product lines within X Company, it is urgent to find the next one The blue ocean market, and the medical testing market requires products with low prices and many testing items. Therefore, for the two dimensions of the localized production of X Company's mass spectrometer equipment and testing kits, according to maintaining the status quo, self-manufacturing and outsourcing production, Cross combinations to make eight strategies. According to the analysis of the advantages and disadvantages of products and opportunities, plus the analysis of transaction costs and product launch time, it is concluded that the localized production of mass spectrometer equipment and detection kits of X Company in China is all outsourced, which is the most suitable method. Company X's best strategic choice in China's medical testing market.

Keywords: transaction cost, strategy choice, medical testing market, mass spectrometer